Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide in Radiologically Isolated Syndrome
NCT03122652Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Sep 2017
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in radiologically isolated syndrome (RIS) comparing Teriflunomide with Placebo (2 arms). Primary endpoint: Time to the first acute or progressive neurological event resulting from CNS demyelination at 96 weeks. Started Sep 2017; status: completed.
02
Drugs
teriflunomide
03
Conditions
radiologically isolated syndrome (RIS)
Beyond the preview
Go deeper on NCT03122652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03122652.